← Back to catalogue

Validate

FDA UDI

Class I (US FDA UDI)

by LGC Clinical Diagnostics, Inc.

Identity

Trade Name
Validate FDA UDI
Generic Name
Cyclic citrullinated peptide antibody (anti-CCP) IVD, control FDA UDI
Device Name
Anti-CCP Calibration Verification / Linearity Test Kit FDA UDI
Model / Reference
210re FDA UDI
Description
Anti-CCP Calibration Verification / Linearity Test Kit FDA UDI

Identifiers

Primary DI / UDI-DI
00850011135594 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Cyclic citrullinated peptide antibody (anti-CCP) IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cyclic citrullinated peptide antibody (anti-CCP) IVD, control

Validate by LGC Clinical Diagnostics, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cyclic citrullinated peptide antibody (anti-CCP) IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI fbe1fe3c-2d23-442a-99d7-ad1409647204 35 fields · synced Jun 9, 2026